← Browse by Condition
Medical Condition

relapsed refractory acute myeloid leukemia aml

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05143996 Phase 1
Recruiting

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Enrollment
60 pts
Location
United States
Sponsor
Cullinan Therapeutics Inc.
View Trial →